1. Stay up to date with industry knowledge to ensure you are on top of all the latest developments in Oncolytic Virotherapy
2. Place yourself as an industry thought leader and join in the debates with senior experts from Pharmaceuticals, Biotech, Academia and the wider community.
3. Real case studies and keynote presentations revealing new data from the latest research
4. Network with decision makers who are work class experts in Oncolytic Virotherapy VPs, Professors, Directors, and more from world renowned institutions.
5. The only conference in Europe dedicated specifically to the Oncolytic Virotherapy and its drug development
6. Discover the latest developments for clinically relevant models in preclinical trials to enhance your drug development
7. Progress your Oncolytic Virotherapy research from correlative hypotheses to causative understanding that delve deeper into specific knowledge
8. Overcome the clinical challenges specific to Oncolytic Virotherapy drug development including clinical trial design, scaling up and industrial manufacturing
9. Gain appreciation for the translational applications of Oncolytic Virotherapy and combination therapies
10. Anticipate the evolving regulatory landscape facing Oncolytic Virotherapy therapies to ensure that you are up to date with the latest discussions.